The identification of drug candidates typically begins with high-throughput screening of large compound libraries. Researchers use various bioanalytical techniques, such as mass spectrometry and nuclear magnetic resonance, to screen for compounds that interact with specific biological targets. Advances in computational chemistry and molecular docking also play a crucial role in predicting potential drug-receptor interactions.
